Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
about
Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of SubgroupsThe Relationship between Obstructive Sleep Apnea and Atrial Fibrillation: A Complex InterplayHeart Disease and Stroke Statistics--2013 Update: A Report From the American Heart AssociationEarly-life antecedents of atrial fibrillation: place of birth and atrial fibrillation-related mortalityConcomitant atrial fibrillation surgery for people undergoing cardiac surgeryEffectiveness of systematic screening for the detection of atrial fibrillationFactor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillationInterventions for preventing post-operative atrial fibrillation in patients undergoing heart surgeryEducational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillationOral anticoagulants versus antiplatelet therapy for preventing stroke and systemic embolic events in patients with atrial fibrillationEffectiveness of systematic screening for the detection of atrial fibrillationFactor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillationEducational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillationOral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacksOral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacksAntiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacksAnticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attackOral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacksAnticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attackAugmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillationDefects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillationCollaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsCost of AF Ablation: Where Do We Stand?Left atrial appendage: structure, function, and role in thromboembolismKCNQ potassium channel mutations cause cardiac arrhythmias in Drosophila that mimic the effects of aging.Sinus versus nonsinus tachycardia in the emergency department: importance of age and heart rateA randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732]Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN893Anticoagulation for non-valvular atrial aibrillation - towards a new beginning with ximelagatranSystematic screening for the detection of atrial fibrillationBiomarkers and the prediction of atrial fibrillation: state of the artHow and When to Screen for Atrial Fibrillation after Stroke: Insights from Insertable Cardiac Monitoring DevicesAtrial fibrillation and silent stroke: links, risks, and challengesCellular and Molecular Mechanisms of Arrhythmia by Oxidative StressAtrial Fibrillation is Associated With Poor Outcomes in Thrombolyzed Patients With Acute Ischemic Stroke: A Systematic Review and Meta-AnalysisSurgical perspectives in the management of atrial fibrillationAtrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studiesStroke Event Rates and the Optimal Antithrombotic Choice of Patients With Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsBrain-heart axis--Review ArticlePostoperative atrial fibrillation in patients undergoing non-cardiac non-thoracic surgery: A practical approach for the hospitalist
P2860
Q21284803-3066B340-9311-42AB-BC3E-F90D8FC247ABQ21284813-224CE3EF-221B-451D-A195-E3E298B21CF4Q22306356-38ABC6D3-765F-43B4-AA04-01B84D2CBE26Q23916376-6FD75407-2208-4F8E-8828-B4373E61989CQ24188130-EEB64E16-DDF7-44C3-84B9-E70855DB0135Q24197923-A4047049-E9E4-4A86-A1A5-034388BBF0B7Q24200497-2A16DE82-E75F-422C-8680-B8F7C3963C02Q24201618-0D8AD041-3055-4162-B24D-7BADE3C63F03Q24202280-49E46863-2CF7-406A-B61F-E16043E63852Q24203797-B261F1ED-5830-47FE-A692-C815938C634EQ24203942-35646065-DB44-4B3A-9398-9CA890F6A51AQ24234397-44CD546F-9CE1-4BF3-AE5E-35B6085055B4Q24234691-A188367A-C3E5-4B86-B04E-AD26A52B7638Q24244298-161B5DC4-C7D2-446C-A70C-1CE115EF1B81Q24244742-764FDBD4-6F71-44BB-9147-C493B6E3EA90Q24245569-7004CA6E-8167-4B04-99C3-532EA6C05E70Q24245863-280055FD-AB8B-416A-B054-471595227C19Q24246644-7AA912FF-0F25-4930-A30F-B5254F157D6AQ24247247-92A27E2D-4FA1-4415-962F-D4A4459C9C2CQ24318897-566B2BE8-744B-4B87-B80D-28D6690F3D43Q24324744-E06ED627-0887-4C98-A159-6BB63CA9423FQ24555072-ED4B5A1A-D6C2-4E6D-89F2-93FBE97D66ACQ24605888-D1CA738C-F345-4FEF-9392-B477113E6113Q24670160-0A6B99D0-FE10-4D07-A551-2D8599573677Q24681227-010EAEB3-BAB9-4E14-B77A-1DFA5343D3E1Q24795392-B2A80470-BEDF-4661-AD0A-CF1213212D8AQ24798085-AB7B7B09-FFBD-4791-8164-54160DDC13F3Q24801915-194FD18C-4359-48C1-B672-6393DC1C28F9Q24807132-E902A827-7703-46DE-A94C-E9230276278EQ26471549-D38E5801-BF06-423E-87E9-01598E8DF892Q26739847-116EB3D1-991B-4C4B-8E08-072724D4EBD7Q26747267-C62D0F14-9A3D-4459-A40F-818CCA9E572DQ26750435-74FE531A-16E7-4D6F-9383-E159E4768CF3Q26765076-BF22230E-5019-493E-9E62-D1641E5740AFQ26766563-3286A61F-96A4-471D-8860-8510745BAE34Q26769985-9E22D778-913A-45CB-97B6-689861587B8FQ26770901-E2BDBE56-EDA0-42BA-B9EA-CB234F2E2CB2Q26771564-C592861D-DD27-4775-93E0-510CF4043832Q26782446-AA8CDC7E-18DE-41E3-B449-2DB933DD6D42Q26785568-0A63B1A7-5E3F-4213-BE4C-749CE86D4013
P2860
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
description
1991 nî lūn-bûn
@nan
1991 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
@ast
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
@en
type
label
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
@ast
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
@en
prefLabel
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
@ast
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
@en
P2093
P3181
P356
P1433
P1476
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
@en
P2093
P3181
P356
10.1161/01.STR.22.8.983
P407
P577
1991-08-01T00:00:00Z